Vaccine hopes rise as jab shows promising immune response
Experimental vaccines generated 'robust immune responses' in a group of healthy adults aged between 18 and 55, report says
26 October 2020 - 17:06
London — One of the world’s leading Covid-19 experimental vaccines produces an immune response in both young and old adults, raising the hope of a path out of the gloom and economic destruction wrought by the novel coronavirus.
The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, British drugmaker AstraZeneca, which is helping manufacture the vaccine, said on Monday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.